The story of Viagra and its influence on the pharmaceutical sector presents a intricate question regarding its escort continued viability as an investment. Initially a remarkable success, generating vast revenues, generic competition has substantially eroded financial returns. While major pharmaceutical firms maintain patents on related therapies a

The trajectory of companies tied to iconic drugs like Viagra presents a nuanced investment scenario . While the initial surge of copyright, fueled by Viagra's remarkable popularity, generated substantial returns, the loss of exclusivity in key regions has introduced substantial uncertainty . Investors are now grappling with the consequences of gene